An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome (Q35595584)
Jump to navigation
Jump to search
scientific article published on May 1, 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome |
scientific article published on May 1, 2003 |
Statements
1 reference
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome (English)
1 reference
J. Kellow
O. Y. Lee
F. Y. Chang
S. Thongsawat
M. Z. Mazlam
H. Yuen
K. A. Gwee
J. Jones
1 May 2003
1 reference
1 reference
52
1 reference
5
1 reference
671-676
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference